 | Up a level |
Mohamad, Osama; Nicosia, Luca; Mathier, Etienne; Riggenbach, Elena; Zamboglou, Constantinos; Aebersold, Daniel M; Alongi, Fillipo; Shelan, Mohamed (2024). Focal brachytherapy as definitive treatment for localized prostate cancer: A systematic review and meta-analysis. (In Press). Brachytherapy Elsevier 10.1016/j.brachy.2024.01.011
Mathier, Etienne; Althaus, Alexander; Zwahlen, Daniel; Lustenberger, Jens; Zamboglou, Constantinos; De Bari, Berardino; Aebersold, Daniel M; Guckenberger, Matthias; Zilli, Thomas; Shelan, Mohamed (2024). HypoFocal SRT Trial: Ultra-hypofractionated focal salvage radiotherapy for isolated prostate bed recurrence after radical prostatectomy; single-arm phase II study; clinical trial protocol. BMJ open, 14(e075846) BMJ Publishing Group 10.1136/bmjopen-2023-075846
Schröder, Christina; Mose, Lucas; Mathier, Etienne; Zwahlen, Daniel Rudolf; Aebersold, Daniel Matthias; Förster, Robert; Shelan, Mohamed (2023). Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers, 15(24) MDPI AG 10.3390/cancers15245815
Mathier, Etienne; Heusel, Astrid; Shelan, Mohamed (2022). [Multimodality treatment in high-risk and very high-risk prostate cancer: outcomes from international phase III randomized controlled trials]. Strahlentherapie und Onkologie, 198(10), pp. 962-965. Springer 10.1007/s00066-022-01968-5
Beck, Marcus; Sassowsky, Manfred; Schär, Sämi; Mathier, Etienne; Zwahlen, Daniel R; Hölscher, Tobias; Arnold, Winfried; Polat, Bülent; Hildebrandt, Guido; Müller, Arndt-Christian; Putora, Paul M.; Papachristofilou, Alexandros; Hayoz, Stefanie; Schär, Corinne; Li, Qiyu; Sumila, Marcin; Zaugg, Kathrin; Guckenberger, Matthias; Ost, Piet; Bosetti, Davide G; ... (2022). Adherence to contouring and treatment planning requirements within a multicentric trial -results of the quality assurance of the SAKK 09/10 trial. International journal of radiation oncology, biology, physics, 113(1), pp. 80-91. Elsevier 10.1016/j.ijrobp.2021.12.174
Eliçin, Olgun; Vollnberg, Bernd; Shelan, Mohamed; Riggenbach, Elena; Bojaxhiu, Beat; Mathier, Etienne; Giger, Roland; Aebersold, Daniel M.; Klaeser, Bernd (2021). Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer. Clinical and translational radiation oncology, 31, pp. 8-13. Elsevier 10.1016/j.ctro.2021.08.007
Hemmatazad, Hossein; Mathier, Etienne; Aebersold, Daniel M.; Shelan, Mohamed (2021). [Single dose of 24 Gy or 3-fraction SBRT regimen in the treatment of oligometastatic cancer? : A phase III multi-center trial]. Strahlentherapie und Onkologie, 197(9), pp. 859-861. Springer 10.1007/s00066-021-01806-0
Eliçin, Olgun; Koller Brolese, Eliane; Bojaxhiu, Beat; Sermaxhaj, Burim; Schanne, Daniel Hendrik; Mathier, Etienne; Lippmann, Jana; Shelan, Mohamed; Eller, Yannick; Aebersold, Daniel Matthias; Giger, Roland; Cihoric, Nikola (2021). The prognostic impact of daytime and seasonality of radiotherapy on head and neck cancer. Radiotherapy and oncology, 158, pp. 293-299. Elsevier 10.1016/j.radonc.2021.04.004
Koller Brolese, Eliane; Cihoric, Nikola; Bojaxhiu, Beat; Sermaxhaj, Burim; Schanne, Daniel Hendrik; Mathier, Etienne; Lippmann, Jana; Shelan, Mohamed; Eller, Yannick; Aebersold, Daniel M.; Giger, Roland; Eliçin, Olgun (2021). The impact of delivery daytime and seasonality of radiotherapy for head and neck cancer on toxicity burden. Radiotherapy and oncology, 158, pp. 162-166. Elsevier 10.1016/j.radonc.2021.02.039
Goeggel Simonetti, Barbara; Hulliger, Justine; Mathier, Etienne; Jung, Simon; Fischer, Urs; Sarikaya, Hakan; Slotboom, Johannes; Schroth, Gerhard; Mordasini, Pasquale; Gralla, Jan; Arnold, Marcel (2019). Iatrogenic Vessel Dissection in Endovascular Treatment of Acute Ischemic Stroke. Clinical neuroradiology, 29(1), pp. 143-151. Springer 10.1007/s00062-017-0639-z
Cihoric, Nikola; Tsikkinis, Alexandros; Minniti, Giuseppe; Lagerwaard, Frank J; Herrlinger, Ulrich; Mathier, Etienne; Soldatovic, Ivan; Jeremic, Branislav; Ghadjar, Pirus; Eliçin, Olgun; Lössl, Kristina; Aebersold, Daniel; Belka, Claus; Herrmann, Evelyn; Niyazi, Maximilian (2017). Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov. Radiation oncology, 12(1), p. 1. BioMed Central 10.1186/s13014-016-0740-5
Eliçin, Olgun; Terribilini, Dario; Shelan, Mohamed; Volken, Werner; Mathier, Etienne; Dal Pra, Alan; Aebersold, Daniel; Fix, Michael; Manser, Peter (2017). Primary tumor volume delineation in head and neck cancer: missing the tip of the iceberg? Radiation oncology, 12(1), p. 102. BioMed Central 10.1186/s13014-017-0838-4
Heldner, Mirjam Rachel; Nedelcheva, Mila; Yan, Xin; Slotboom, Johannes; Mathier, Etienne; Hulliger, Justine; Verma, Rajeev Kumar; Sturzenegger, Matthias; Jung, Simon; Bernasconi, Corrado Angelo; Arnold, Marcel; Wiest, Roland; Fischer, Urs (2015). Dynamic changes of intramural hematoma in patients with acute spontaneous internal carotid artery dissection. International journal of stroke, 10(6), pp. 887-892. Blackwell Publishing 10.1111/ijs.12553
Shelan, Mohamed; Mohamad, Osama; Nicosia, Luca; Mathier, Etienne; Riggenbach, Elena; Zamboglou, Constantinos; Alongi, Filippo; Aebersold, D. M. (18 September 2023). Focal brachytherapy as definitive treatment for localized prostate cancer: a systematic review and meta-analysis. Strahlentherapie und Onkologie, 11(199), p. 1044. Springer
Mathier, Etienne; Dervishi, Gezim; Althaus, Alexander Maria Georg; Schanne, Daniel Hendrik; Aebersold, Daniel Matthias; Shelan, Mohamed (17 January 2023). Risk of bleeding following robotic stereotactic body radiation therapy in patients with localized prostate cancer in patients receiving baseline anticoagulant or antiplateletherapy. Strahlentherapie und Onkologie, p. 225. Springer
Shelan, Mohamed; Althaus, Alexander Maria Georg; Mathier, Etienne; Schanne, Daniel Hendrik; Aebersold, Daniel Matthias (17 January 2023). Biochemical control after robotic stereotactic body radiation therapy for unfavorable intermediate and high-risk prostate cancer: a single institutional experience with mid-term followup. Strahlentherapie und Onkologie, p. 225. Springer
Schröder, Christina; Mose, Lucas; Förster, Robert; Mathier, Etienne; Zwahlen, Daniel R.; Aebersold, D. M.; Shelan, Mohamed (2023). Five fractions versus seven fractions SBRT for intermediate and high risk prostate cancer: a propensity score matched pair analysis. Strahlentherapie und Onkologie, 11(199), p. 1049. Springer
